Carlos Alcala Marquez, M.D.
NPI 1295066124 · Pulmonary Disease Physician · San Juan, PR
Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1295066124
- Entity type
- Individual
- Primary specialty
- Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 247245 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
16 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
208 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Test to Measure Largest Amount of Air Breathed in an Out94200 | 48 | $15 |
| Test to Measure Rate of Airflow94375 | 48 | $38 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 43 | $89 |
| Evaluation of Use of Breathing Device94664 | 38 | $18 |
| Inhalation Treatment for Airway Obstruction Or Sputum Production94640 | 31 | $8 |
Typical Medicare-allowed amounts for these services range $8–$89 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 31 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Montelukast Sodium | 2,012 | 407 |
| Fluticasone/Vilanterolbrand: Breo Ellipta | 1,218 | 237 |
| Fluticasone Propionate | 1,130 | 241 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 1,117 | 362 |
| Fluticasone Propion/Salmeterolbrand: Wixela Inhub | 992 | 206 |
| Desloratadine | 596 | 136 |
| Famotidine |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$466 across 20 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2010-01-15
- Last updated
- 2010-05-11
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.